Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Nikkei snaps 7-day losing streak helped by China's stimulus hopes

Wed, 15th May 2019 08:05

* Gains may be short-lived - analyst

* Takeda Pharma, Nissan sink after earnings shock

* Mitsubishi Estate jumps on share buyback, governancereform

By Hideyuki Sano and Ayai Tomisawa

TOKYO, May 15 (Reuters) - Japan's Nikkei ended higher inchoppy trade on Wednesday, snapping a seven-day losing streak,as expectations that China could roll out fresh stimulus to propup a slowing economy supported stocks in the region.

The Nikkei share average ended 0.6% higher at21,288.56, after trading in negative territory in the morning.It had dropped for seven straight days.

The broader Topix, which hit a four-month low theprevious day, rose 0.6% to 1,544.15.

"The market turned around on hopes that China will launchstimulus measures to tackle the weak economy, but the gains maybe short-lived as it was just hopes at this point," said YutakaMiura, a senior technical analyst at Mizuho Securities.

U.S. futures also rose 0.2% indicating a positiveopen for U.S. stocks later in the day.

Exporters gained with Sony Corp up 4%, Subaru Corprising 2.7% and Hitachi Ltd 2.6% higher.

Meanwhile, Japanese corporate earnings disappointed themarket, with net profits falling almost 5.0% from a year earlierin January-March, according to Okasan Securities.

Takeda Pharmaceutical plunged 7.8% after Japan'sbiggest drugmaker forecast an unexpected operating loss for thecurrent year due to costs associated with the $59 billionpurchase of Shire Plc.

That weighed on Tokyo Stock Exchange's drugmaker subindex3%, making it the worst performer.

Nissan Motor slumped 6.5% after the carmakerforecast the weakest profit outlook in more than a decade.

"The earnings results suggested that the company is in muchworse shape than I have imagined," said Hiroshi Masushima,market analyst at Monex Securities.

The carmaker, hit by former chairman Carlos Ghosn's arrestlast year and troubles at its North American business, also saidits dividend will be cut about 30% in another blow to investorsas its hefty payouts have been the only major attraction.

H2O Retailing stumbled 11% as the mid-tierdepartment store operator posted weak earnings and guidance.

On the upside, Mitsubishi Estate jumped 9.2% afterthe real estate developer announced its first share buyback anda plan to abolish anti-takeover steps.(Editing by Sam Holmes)

Related Shares

More News
6 Sep 2019 07:54

UPDATE 1-Sumitomo Dainippon Pharma investing $3 bln in Swiss Roivant in overseas push

* Dainippon to buy 10% stake in Roivant and interests in 5 units * Schizophrenia treatment Latuda to lose US exclusivity in 2023 * Japan pharma firms ...

14 Aug 2019 06:45

UPDATE 1-Germany's Stada 'very selective' on acquisitions - CEO Goldschmidt

FRANKFURT, Aug 14 (Reuters) - German generic drugmaker Stada will be careful about buying businesses and companies outright, and for now will focus ma...

17 Jul 2019 17:55

Takeda kicks off sale of Western European drugs - sources

By Arno Schuetze and Pamela Barbaglia FRANKFURT/LONDON, July 17 (Reuters) - Japan's Takeda Pharmaceutical Co has reached out to prospective bidders fo...

16 May 2019 18:35

Japan's Takeda expects binding offers for Latam business by end of May -sources

By Tatiana Bautzer SAO PAULO, May 16 (Reuters) - Japan's Takeda Pharmaceutical Co expects to receive binding offers for its Latin American business by...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.